Rockefeller University researchers found that low arginine levels reduce production of MHC‑I, a critical signal that alerts the immune system to infected or mutated cells. In cell and mouse studies, moderate arginine supplementation restored MHC‑I and improved outcomes after viral infection. The findings, published in Cell, suggest potential benefits for immunity and aging, but human trials are needed before clinical recommendations can be made.
Arginine Restores the Immune “Warning System” That Helps Detect Cancer and Viruses
(Dreamstime)
Researchers at Rockefeller University report that reduced levels of the amino acid arginine can lower production of MHC‑I, a key cellular “warning system” that helps the immune system recognize infected or mutated cells. Their new work, published in the journal Cell, shows that restoring arginine levels can reinstate MHC‑I production and improve outcomes in experimental models.
What the Study Found
The team analyzed how arginine depletion — from poor diet or disease — alters gene expression in settings that included colon cancer, influenza and SARS‑CoV‑2 infection. They observed markedly reduced arginine in all of these conditions and linked the deficiency to lower expression of major histocompatibility complex class I (MHC‑I), the protein complex that displays internal cell abnormalities to the immune system.
In cell and animal experiments, even a moderate increase in arginine (the authors compare it to the amount in a couple of over‑the‑counter tablets) restored MHC‑I production. Mice fed an arginine‑enriched diet experienced milder symptoms and better outcomes following viral infections; giving arginine after influenza infection also improved recovery.
“Our work reveals how a lack of arginine interferes with the immune system, and suggests that upping arginine intake could prove beneficial,” said Qiushuang Wu, a postdoctoral associate at Rockefeller. “Perhaps that means it could be used in combination with other therapies to treat both cancer and viral infections.”
Sources, Implications, and Cautions
Arginine is a semi‑essential amino acid produced by the body and found in protein‑rich foods such as meat, fish, poultry, nuts and seeds. It plays many roles including protein synthesis, supporting blood flow, and modulating immune cell activity. The researchers suggest that declining arginine levels with age could partly explain increased vulnerability to some cancers and infections.
Important caution: These findings are primarily preclinical. While the results are promising, human clinical trials are needed to determine whether dietary arginine supplements or other strategies to raise arginine safely improve immune detection of cancer or viral infections. Readers should not change medication or supplement routines without consulting a healthcare professional.
Next Steps
The authors plan further studies to test whether boosting dietary amino acids can raise arginine levels in humans and whether that improves immune surveillance in aging or disease. If confirmed in clinical trials, arginine modulation could become a complementary approach alongside existing immunotherapies.
Help us improve.
